US Patent 8043833 Expression of soluble therapeutic proteins
Patent 8043833 was granted and assigned to Novo Nordisk on October, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8043833 Expression of soluble therapeutic proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
